J3393 – Injection, betibeglogene autotemcel, per treatment
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ3393
- Long description
- Injection, betibeglogene autotemcel, per treatment
- Short description
- Inj, betibeglogene autotemce
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- July 1, 2024
- Last change
- July 1, 2024 – No change
Frequently asked questions
What is HCPCS code J3393?
J3393 is a HCPCS Level II code for injection, betibeglogene autotemcel, per treatment.
Does Medicare cover J3393?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J3379 – Injection, valproate sodium, 5 mg
- J3380 – Injection, vedolizumab, intravenous, 1 mg
- J3385 – Injection, velaglucerase alfa, 100 units
- J3386 – Injection, etuvetidigene autotemcel, per treatment
- J3387 – Injection, elivaldogene autotemcel, per treatment
- J3389 – Topical administration, prademagene zamikeracel, per treatment
- J3391 – Injection, atidarsagene autotemcel, per treatment
- J3392 – Injection, exagamglogene autotemcel, per treatment
- J3394 – Injection, lovotibeglogene autotemcel, per treatment
- J3396 – Injection, verteporfin, 0.1 mg
- J3397 – Injection, vestronidase alfa-vjbk, 1 mg
- J3398 – Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
- J3399 – Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes
- J3400 – Injection, triflupromazine hcl, up to 20 mg
- J3401 – Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
- J3402 – Injection, remestemcel-l-rknd, per therapeutic dose
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.